NS

Niketa Singh

Active Director Director DIN 08796513
DIN 08796513 First appointment Jul 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since Jul 2020
Shareholding value •••• Premium profile

About Niketa Singh

Data last updated:

Niketa Singh is a Director at Unisars Health Care Private Limited (since 2020), Director at Jiyo India Private Limited (since 2020) and Director at Niu Infratech Private Limited (since 2020), and holds 3 more current directorships. The companies operate in Trading, Pharma and Construction. The 3 current companies with reported revenue have a combined latest revenue of ₹18.4 Lakh; the largest is Unisars Health Care Private Limited at ₹17 Lakh (FY 2025). Earlier, Niketa Singh was a Director at Jiyo India Sales & Marketing Private Limited (2020–2024).

DIN 08796513
Primary Designation Director
Industry Trading
First Appointment 16 Jul 2020
Oldest Company Age 19 yrs
Largest company Unisars Health Care Private Limited · ₹17 Lakh (FY 2025)
Combined revenue ₹18.4 Lakh across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Unisars Health Care Private Limited U74900UP2009PTC038755
Director16 Jul 20202009₹17 Lakh (FY 2025)Active
Jiyo India Private Limited U74999UP2016PTC082859
Director16 Jul 20202016₹1.1 Lakh (FY 2017)Active
Niu Infratech Private Limited U70102UP2011PTC046599
Director16 Jul 20202011₹35,985 (FY 2024)Active
Orbit Colonizers Private Limited U45400UP2007PTC033942
Director16 Jul 20202007Active
Iskcon Infraventure Private Limited U70102UP2011PTC044009
Director16 Jul 20202011Active
Akss Beauty India Private Limited U93000UP2009PTC037982
Director16 Jul 20202009Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jul 20202011₹26.3 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Niketa Singh

NameDINCompanyDesignation
Savita Singh07456891Unisars Health Care Private Limited , Jiyo India Private Limited and 4 moreDirector

Directorship timeline

Open interactive timeline →
Orbit Colonizers Private Limited
Iskcon Infraventure Private Limited
Niu Infratech Private Limited
Unisars Health Care Private Limited
Premium access

Shareholding and investment profile for Niketa Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Niketa Singh

Niketa Singh currently holds 6 directorships: Unisars Health Care Private Limited (Director, since 16 Jul 2020, revenue ₹17 Lakh (FY 2025)); Jiyo India Private Limited (Director, since 16 Jul 2020, revenue ₹1.1 Lakh (FY 2017)); Niu Infratech Private Limited (Director, since 16 Jul 2020, revenue ₹35,985 (FY 2024)); Orbit Colonizers Private Limited (Director, since 16 Jul 2020); Iskcon Infraventure Private Limited (Director, since 16 Jul 2020); and 1 more.

Niketa Singh was first appointed on 16 Jul 2020 as Director at Unisars Health Care Private Limited.

The 3 current companies of Niketa Singh that report revenue have a combined latest revenue of ₹18.4 Lakh: Unisars Health Care Private Limited ₹17 Lakh (FY 2025); Jiyo India Private Limited ₹1.1 Lakh (FY 2017); Niu Infratech Private Limited ₹35,985 (FY 2024).

Niketa Singh held 1 earlier board appointment: Jiyo India Sales & Marketing Private Limited (Director, 16 Jul 2020 to 09 Aug 2024).

The current boards of Niketa Singh's companies include Savita Singh (Unisars Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available